UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy

Indian journal of endocrinology and metabolism, 2015-11, Vol.19 (6), p.764-769

2015

Volltextzugriff (PDF)

CSII as an Alternative Therapeutic Strategy for Managing Type 2 Diabetes: Adding the Indian Experience to a Global Perspective

Current diabetes reviews, 2016-12, Vol.12 (4), p.312-314

2016

Volltextzugriff (PDF)

Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)

Endocrine Connections, 2017-11, Vol.6 (8), p.748-757

2017

Volltextzugriff (PDF)

1048-P: Assessing the Quality of Life of People with Diabetes Adhering to Telemedicine over 15 Years

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

440-P: Complications of Diabetes after 15 Years—Comparing Telemedicine with Conventional Care

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

685-P: Will Choice of Treatment Influence TIR in T2D with Diabetic Complications?

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

810-P: Real-World Performance of IDegAsp over Six Years in Asian-Indian Population

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

1049-P: Pros and Cons of Telemedicine in Diabetes—Survey among Doctors and Allied HCPs

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

The Effect of Glycemic Control Achieved through Routine Follow-up on CA19-9 Levels

Metabolism, clinical and experimental, 2021-03, Vol.116, p.154516, Article 154516

2021

Volltextzugriff (PDF)

Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System

Diabetes therapy, 2023-08, Vol.14 (8), p.1319-1330

2023

Volltextzugriff (PDF)

853-P: Comparing Telemedicine with Conventional Diabetes Care in Assessing Long-Term Outcomes in 451 Patients over 15 Years

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

468-P: Impact of Webinars and Telemedicine during COVID-19 Lockdown in Transforming Outcomes in 848 T2D Patients in India

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

Comparing the benefits of applying a vacuum assisted lancing device in reducing lancing pain, improving self-monitoring frequency and reducing HbA1c in people with diabetes

Diabetes & metabolic syndrome clinical research & reviews, 2023-03, Vol.17 (3), p.102731-102731, Article 102731

2023

Volltextzugriff (PDF)

880-P: Is Time-in-Range Independent of A1C? A Study in Asian Indian Population

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

Emotional and Social Dimensions of the Parents of Children with Type 1 Diabetes: A Survey-based Cross-sectional Study

International Journal of Diabetes and Technology, 2023-10, Vol.2 (4), p.103-108

2023

Volltextzugriff (PDF)

WhatsApp Support Group for 950 Children and Adolescents/Parents with Type 1 Diabetes – Physician’s Perspective on Merits and Demerits

International Journal of Diabetes and Technology, 2023-07, Vol.2 (3), p.100-101

2023

Volltextzugriff (PDF)

IDegAsp Improves Glycemic Control with Minimal Hypoglycemia—An Indian Real-World Study in T2D Subjects

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

530-P: Early Insulin Initiation in T2DM Is Associated with Prevention of eGFR Decline and Lower Insulin Dose Requirements

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

Assessing the Therapeutic Utility of Professional Continuous Glucose Monitoring in Type 2 Diabetes Across Various Therapies: A Retrospective Evaluation

Advances in therapy, 2017-08, Vol.34 (8), p.1918-1927

2017

Volltextzugriff (PDF)

Comparing Points in Target Range Assessed by Blood Glucose Monitoring Using a Vacuum-based Lancing Device and Conventional Lancing Devices

International Journal of Diabetes and Technology, 2022-07, Vol.1 (3), p.111-113

2022

Volltextzugriff (PDF)

Prevalence of Adverse Events of Pneumococcal and Influenza Vaccines among People with Diabetes

International Journal of Diabetes and Technology, 2023-07, Vol.2 (3), p.90-94

2023

Volltextzugriff (PDF)

Cost-effective use of telemedicine and self-monitoring of blood glucose via Diabetes Tele Management System (DTMS) to achieve target glycosylated hemoglobin values without serious symptomatic hypoglycemia in 1,000 subjects with type 2 diabetes mellitus--a retrospective study

Diabetes technology & therapeutics, 2012-09, Vol.14 (9), p.772-776

2012

Volltextzugriff (PDF)

Type 2 Diabetes in Women: Differences and Difficulties

Current diabetes reviews, 2022-10, Vol.18 (8)

2022

Volltextzugriff (PDF)

Are Complications Preventable with Periodic Education via Telemedicine? A Study of 414 Compliant T2D Patients Followed Up for 19 Years

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

How Can Diabetes Technologies Reduce the Burden of Cost?

International Journal of Diabetes and Technology, 2022-01, Vol.1 (1), p.13-19

2022

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(49)

Sprache

Englisch
(49)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy

CSII as an Alternative Therapeutic Strategy for Managing Type 2 Diabetes: Adding the Indian Experience to a Global Perspective

Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)

1048-P: Assessing the Quality of Life of People with Diabetes Adhering to Telemedicine over 15 Years

440-P: Complications of Diabetes after 15 Years—Comparing Telemedicine with Conventional Care

685-P: Will Choice of Treatment Influence TIR in T2D with Diabetic Complications?

810-P: Real-World Performance of IDegAsp over Six Years in Asian-Indian Population

1049-P: Pros and Cons of Telemedicine in Diabetes—Survey among Doctors and Allied HCPs

The Effect of Glycemic Control Achieved through Routine Follow-up on CA19-9 Levels

Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System

853-P: Comparing Telemedicine with Conventional Diabetes Care in Assessing Long-Term Outcomes in 451 Patients over 15 Years

468-P: Impact of Webinars and Telemedicine during COVID-19 Lockdown in Transforming Outcomes in 848 T2D Patients in India

Comparing the benefits of applying a vacuum assisted lancing device in reducing lancing pain, improving self-monitoring frequency and reducing HbA1c in people with diabetes

880-P: Is Time-in-Range Independent of A1C? A Study in Asian Indian Population

Emotional and Social Dimensions of the Parents of Children with Type 1 Diabetes: A Survey-based Cross-sectional Study

WhatsApp Support Group for 950 Children and Adolescents/Parents with Type 1 Diabetes – Physician’s Perspective on Merits and Demerits

IDegAsp Improves Glycemic Control with Minimal Hypoglycemia—An Indian Real-World Study in T2D Subjects

530-P: Early Insulin Initiation in T2DM Is Associated with Prevention of eGFR Decline and Lower Insulin Dose Requirements

Assessing the Therapeutic Utility of Professional Continuous Glucose Monitoring in Type 2 Diabetes Across Various Therapies: A Retrospective Evaluation

Comparing Points in Target Range Assessed by Blood Glucose Monitoring Using a Vacuum-based Lancing Device and Conventional Lancing Devices

Prevalence of Adverse Events of Pneumococcal and Influenza Vaccines among People with Diabetes

Cost-effective use of telemedicine and self-monitoring of blood glucose via Diabetes Tele Management System (DTMS) to achieve target glycosylated hemoglobin values without serious symptomatic hypoglycemia in 1,000 subjects with type 2 diabetes mellitus--a retrospective study

Type 2 Diabetes in Women: Differences and Difficulties

Are Complications Preventable with Periodic Education via Telemedicine? A Study of 414 Compliant T2D Patients Followed Up for 19 Years

How Can Diabetes Technologies Reduce the Burden of Cost?

Suchergebnisse filtern